134 related articles for article (PubMed ID: 25812569)
1. Identification of potential targets for diallyl disulfide in human gastric cancer MGC-803 cells using proteomics approaches.
Su B; Su J; He H; Wu Y; Xia H; Zeng X; Dai W; Ai X; Ling H; Jiang H; Su Q
Oncol Rep; 2015 May; 33(5):2484-94. PubMed ID: 25812569
[TBL] [Abstract][Full Text] [Related]
2. Diallyl disulfide suppresses epithelial-mesenchymal transition, invasion and proliferation by downregulation of LIMK1 in gastric cancer.
Su B; Su J; Zeng Y; Liu F; Xia H; Ma YH; Zhou ZG; Zhang S; Yang BM; Wu YH; Zeng X; Ai XH; Ling H; Jiang H; Su Q
Oncotarget; 2016 Mar; 7(9):10498-512. PubMed ID: 26871290
[TBL] [Abstract][Full Text] [Related]
3. DADS downregulates the Rac1-ROCK1/PAK1-LIMK1-ADF/cofilin signaling pathway, inhibiting cell migration and invasion.
Zhou Y; Su J; Shi L; Liao Q; Su Q
Oncol Rep; 2013 Feb; 29(2):605-12. PubMed ID: 23233092
[TBL] [Abstract][Full Text] [Related]
4. [Diallyl disulfide inhibits invasion and metastasis of MCF-7 breast cancer cells in vitro by down-regulating p38 activity].
Chen XX; Liu XW; Zhou ZG; Chen XY; Li LD; Xiong T; Peng L; Tu J
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Jun; 36(6):814-8. PubMed ID: 27320884
[TBL] [Abstract][Full Text] [Related]
5. Diallyl disulfide inhibits growth and metastatic potential of human triple-negative breast cancer cells through inactivation of the β-catenin signaling pathway.
Huang J; Yang B; Xiang T; Peng W; Qiu Z; Wan J; Zhang L; Li H; Li H; Ren G
Mol Nutr Food Res; 2015 Jun; 59(6):1063-75. PubMed ID: 25755089
[TBL] [Abstract][Full Text] [Related]
6. Diallyl sulfide, diallyl disulfide, and diallyl trisulfide inhibit migration and invasion in human colon cancer colo 205 cells through the inhibition of matrix metalloproteinase-2, -7, and -9 expressions.
Lai KC; Hsu SC; Kuo CL; Yang JS; Ma CY; Lu HF; Tang NY; Hsia TC; Ho HC; Chung JG
Environ Toxicol; 2013 Sep; 28(9):479-88. PubMed ID: 21695758
[TBL] [Abstract][Full Text] [Related]
7. Diallyl disulfide selectively causes checkpoint kinase-1 mediated G2/M arrest in human MGC803 gastric cancer cell line.
Ling H; Lu LF; He J; Xiao GH; Jiang H; Su Q
Oncol Rep; 2014 Nov; 32(5):2274-82. PubMed ID: 25176258
[TBL] [Abstract][Full Text] [Related]
8. Quercetin Has Antimetastatic Effects on Gastric Cancer Cells via the Interruption of uPA/uPAR Function by Modulating NF-κb, PKC-δ, ERK1/2, and AMPKα.
Li H; Chen C
Integr Cancer Ther; 2018 Jun; 17(2):511-523. PubMed ID: 28627240
[TBL] [Abstract][Full Text] [Related]
9. Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling.
Xue A; Xue M; Jackson C; Smith RC
Int J Biochem Cell Biol; 2009; 41(8-9):1731-8. PubMed ID: 19433314
[TBL] [Abstract][Full Text] [Related]
10. Effect of diallyl disulfide on insulin-like growth factor signaling molecules involved in cell survival and proliferation of human prostate cancer cells in vitro and in silico approach through docking analysis.
Arunkumar R; Sharmila G; Elumalai P; Senthilkumar K; Banudevi S; Gunadharini DN; Benson CS; Daisy P; Arunakaran J
Phytomedicine; 2012 Jul; 19(10):912-23. PubMed ID: 22739413
[TBL] [Abstract][Full Text] [Related]
11. Chk1, but not Chk2, is responsible for G2/M phase arrest induced by diallyl disulfide in human gastric cancer BGC823 cells.
Bo S; Hui H; Li W; Hui L; Hong X; Lin D; Dai WX; Wu YH; Ai XH; Hao J; Qi S
Food Chem Toxicol; 2014 Jun; 68():61-70. PubMed ID: 24650757
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of matrix metalloproteinase activities and tightening of tight junctions by diallyl disulfide in AGS human gastric carcinoma cells.
Park HS; Kim GY; Choi IW; Kim ND; Hwang HJ; Choi YW; Choi YH
J Food Sci; 2011 May; 76(4):T105-11. PubMed ID: 22417372
[TBL] [Abstract][Full Text] [Related]
13. [Diallyl disulfide-induced G2/M arrest of human gastric cancer MGC803 cells involves activation of p38 MAP kinase pathways].
Yuan JP; Ling H; Zhang MX; Liu Y; Song Y; Su Q
Ai Zheng; 2004 Feb; 23(2):169-72. PubMed ID: 14960237
[TBL] [Abstract][Full Text] [Related]
14. Diallyl disulfide inhibits the proliferation of HT-29 human colon cancer cells by inducing differentially expressed genes.
Huang YS; Xie N; Su Q; Su J; Huang C; Liao QJ
Mol Med Rep; 2011; 4(3):553-9. PubMed ID: 21468607
[TBL] [Abstract][Full Text] [Related]
15. Diallyl disulfide induces downregulation and inactivation of cofilin 1 differentiation via the Rac1/ROCK1/LIMK1 pathway in leukemia cells.
Ling H; Ji X; Lei Y; Jia Y; Liu F; Xia H; Tan H; Zeng X; Yi L; He J; Su Q
Int J Oncol; 2020 Mar; 56(3):772-782. PubMed ID: 32124958
[TBL] [Abstract][Full Text] [Related]
16. Differential proteome expression associated with urokinase plasminogen activator receptor (uPAR) suppression in malignant epithelial cancer.
Saldanha RG; Xu N; Molloy MP; Veal DA; Baker MS
J Proteome Res; 2008 Nov; 7(11):4792-806. PubMed ID: 18808175
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.
Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T
BMC Cell Biol; 2006 Feb; 7():8. PubMed ID: 16504015
[TBL] [Abstract][Full Text] [Related]
18. Growth inhibitory effect and Chk1-dependent signaling involved in G2/M arrest on human gastric cancer cells induced by diallyl disulfide.
Ling H; Wen L; Ji XX; Tang YL; He J; Tan H; Xia H; Zhou JG; Su Q
Braz J Med Biol Res; 2010 Mar; 43(3):271-8. PubMed ID: 20401435
[TBL] [Abstract][Full Text] [Related]
19. Diallyl disulfide-induced G2/M arrest of human gastric cancer MGC803 cells involves activation of p38 MAP kinase pathways.
Yuan JP; Wang GH; Ling H; Su Q; Yang YH; Song Y; Tang RJ; Liu Y; Huang C
World J Gastroenterol; 2004 Sep; 10(18):2731-4. PubMed ID: 15309729
[TBL] [Abstract][Full Text] [Related]
20. Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system.
Lee DH; Yang Y; Lee SJ; Kim KY; Koo TH; Shin SM; Song KS; Lee YH; Kim YJ; Lee JJ; Choi I; Lee JH
Cancer Res; 2003 Aug; 63(15):4648-55. PubMed ID: 12907645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
